Dr. Margaret Jiemin Zhou, MD

Dr. Zhou practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Zhou's NPI, 1184157992, was assigned on April 7, 2017. Dr. Zhou graduated from UCSF School of Medicine in 2017. Dr. Zhou holds California license A169235.

Dr. Zhou's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Zhou's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Zhou to 1 more hospital and 1 medical group, each named with a free account. Dr. Zhou's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zhou practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Zhou's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Zhou is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Zhou is licensed in California.

CMS data shows 97 Medicare services from Dr. Zhou across 5 procedure codes in 2024, for 112 Medicare patients. Medicare paid $13,917 for them.

CMS counts 112 Medicare patients who saw Dr. Zhou in 2024. The largest group is 65 to 74, with 52 patients. 73% of them have high blood pressure, and 71% have high cholesterol. 30% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zhou's median patient age at 55, with 56% women.

In 2024, Dr. Zhou wrote 94 Medicare Part D claims for 63 patients. 89% of them were for generic drugs. CMS names the drug for 57 of them, across 3 drugs with 11 or more claims each, at $943 in total drug cost. In 2020, CMS named 343 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Zhou for performance year 2024, reported as part of a group. Dr. Zhou accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zhou as offering telehealth. CMS counts 172 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Zhou, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 27 papers to Dr. Zhou, published from 2012 to 2024. 2020 was the busiest year, with 5. The most frequent topics are Colonoscopy, Colorectal Neoplasms and Early Detection of Cancer. Dr. Zhou has published most often in Clin Gastroenterol Hepatol. Dr. Zhou's most frequent co-authors are John O'Brien Clarke, MD, Daniel Ezra Freedberg, MD and Uri Ladabaum, MD.

CMS Open Payments shows 76 general payments to Dr. Zhou from 10 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 84% of the total. CapsoVision, Inc. paid the most, $241,601.

Dr. Zhou graduated from UCSF School of Medicine in 2017.

Dr. Zhou is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.